SWOG S1900G

Primary Category:

Treatment Protocols

Disease Category:

Lung, Lung - Non-Small Cell Metastatic

Status:

Open

A Randomized Phase II Study of INC280 (Capmatinib) Plus Osimertinib with or Without Ramucirumab in Participants with EGFR-Mutant, MET-Amplified Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-Study)

See Screening Protocol LUNGMAP

NCT#05642572